Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Predictors and timing of venous thromboembolism and overall survival in lymphoma.

Leukemia & lymphoma·2026

Same author

Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation: The ULTRA-HFIB Pilot.

JACC. Clinical electrophysiology·2025

Same author

Procainamide-facilitated induction of Purkinje premature ventricular contractions in a patient with idiopathic ventricular fibrillation.

HeartRhythm case reports·2025

Same author

Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.

The New England journal of medicine·2024

Same author

Factors Associated With Unmet Supportive Care Needs and Emergency Department Visits and Hospitalizations in Ambulatory Oncology.

JAMA network open·2023

Same author

Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with <i>CREBBP</i> or <i>EP300</i> mutations: an open label phase II study.

Leukemia & lymphoma·2023

Search research articles

Related Experiment Video

Updated: May 17, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Controversies in BMT for lymphoma.

Randy D Gascoyne¹, Craig Moskowitz, Thomas C Shea

¹British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation

|October 24, 2012

Summary

This study highlights advances in treating diffuse large B-cell lymphoma (DLBCL). Understanding DLBCL biology will improve classification and therapies, enhancing treatment outcomes and curability.

Related Experiment Videos

Last Updated: May 17, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Area of Science:

Hematology
Oncology
Molecular Biology

Background:

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of diseases requiring improved treatment strategies.
Current treatments for DLBCL have limitations, necessitating advancements in therapeutic approaches.

Purpose of the Study:

To outline recent advances and future research directions in DLBCL treatment.
To emphasize the importance of understanding DLBCL biology for improved patient classification and therapy.

Main Methods:

Review of recent scientific literature on DLBCL.
Analysis of emerging trends in lymphoma research and treatment.

Main Results:

Advances in understanding DLBCL biology are crucial for precise disease classification.
Targeted therapies based on specific disease biology are expected to improve initial and salvage treatment outcomes.

Conclusions:

Improved classification and targeted therapies will enhance the efficacy of autologous and allogeneic HSCTs in DLBCL.
Integration of maintenance therapies may further improve DLBCL curability, drawing parallels with multiple myeloma treatment successes.